Screener
MiMedx Group MDXG Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by MiMedx Group in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The source filing: MiMedx Group’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001376339-26-000071
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Accrued compensation | (17,055) | (791) |
| Accrued expenses | (157) | 3,528 |
| Other liabilities | (1,632) | (1,067) |
| Net cash flows (used in) provided by operating activities | (8,136) | 19,718 |
| Cash flows from investing activities: | ||
| Cash paid for acquisitions | (5,000) | (700) |
| Purchases of equipment | (1,168) | (556) |
| Patent application costs | (109) | (37) |
Item 1. Financial Statements
FAQ
- What is MiMedx Group's operating cash flow?
- MiMedx Group (MDXG) reported operating cash flow of -$10.02M in Q2 2026.
- How has MiMedx Group's operating cash flow changed year-over-year?
- MiMedx Group's operating cash flow decreased by 169.5% year-over-year, from $14.42M to -$10.02M.
- What is the long-term trend for MiMedx Group's operating cash flow?
- Over 3 years (2022 to 2025), MiMedx Group's operating cash flow has grown at a 57.7% compound annual growth rate (CAGR), from -$18.85M to $74M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.
Ask your AI about MiMedx Group's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude